MAP2K7 and leukemia: To evaluate whether the combination of rapamycin and MP could inhibit JNK activation, through reduced MAP2K7 expression, we measured phospho-JNK (p-JNK) and total JNK (pan-JNK) levels in CCRF-CEM human leukemia cell line post-treatment by western blot.